News About: Pharm. Industry
Whanin forges strategic tie-up with Sandoz Korea
Whanin Pharm said yesterday that it has established a marketing and distribution partnership with Sandoz Korea.
Under the deal, Whanin will be in charge of selling Sandoz’s three antidepressants such as escitalopr...
MundiPharma Korea names new medical directorMundiPharma Korea announce Monday it has appointed as its managing director, Chung Hyung-jin, a renowned expert in clinical field
The company said Chung will lead all of medi...
|
Cuts in drug prices slashed Q3 profits
After the government forced down prices of medicines, local drug makers posted worst performances in the third half of the year, according to Yakup.com, a pharmaceutical information provider.
Citing the data releas...
Pharma conference for Korean drug makers
A pharmaceutical conference titled “'Conference for Pharma Collaboration - between Poland & Korea” kicks off today at a hall of the Korea Pharmaceutical Manufacturers Association (KPMA).
The one-day conference, hos...
Hanwha Pharm teams up with Servier Korea
Hanwha Pharm said Friday that it has established a marketing and distribution partnership with Servier Korea.
Under the deal, Hanwha will be in charge of selling Servier drugs using its domestic distribution netwo...
Two drug firms sanctioned over kickbacks
The Health Insurance Review and Assessment Service said Thursday it ordered two drug companies to cut the prices of 12 of their products by up to 13 percent in punitive measures against illegal kickbacks.
The puni...
19 drug firms gain 184 GMP approvals from oversea
A total of 19 Korean companies received 184 GMP (Good Manufacturing Practice) from foreign countries, according to the Korea Drug Research Association.
The 184 GMP endorsed products include 110 finished drugs and ...
KPMA to toughen punishment for dumping
The Korea Pharmaceutical Manufacturers Association on Wednesday announced a set of measures to toughen the predatory pricing, commonly referred to as “dumping,” to strengthen preventive measures to root out such irreg...
Korean companies struggling to find new growth engines
The government’s forced price cuts for drugs and other medical products covered by National Health Insurance in April has dealt a blow to local pharmaceutical firms.
To cope with a host of unfavorable business cond...
KFDA approves 10 Baraclude generics
Ten Korean pharmaceutical firms, including CJ Pharm, SK Chemicals and Hanmi Pharm, are allowed to produce generic versions of the hepatitis B drug Baraclude, the Korea Food and Drug Administration officials said Thurs...
